Latest Parkinson's disease Stories
REHOVOT, Israel, October 29, 2014 /PRNewswire/ -- Company also reports encouraging partial results from Phase IIa study of continuous, subcutaneously delivered high-dose
Online course will boast global access to this highly in-demand training. Tucson, AZ (PRWEB) October 26, 2014 LSVT Global, Inc.
Alice Lazzarini, PhD, and internationally recognized researcher in neurogenetic disorders, announces the donation of a portion of proceeds
REHOVOT, Israel, October 23, 2014 /PRNewswire/ -- NeuroDerm Ltd., a clinical stage pharmaceutical company developing drugs for central nervous system (CNS) diseases, today
The Parkinson Alliance Reports Findings Pertaining to Autonomic Dysfunction in Parkinson's KINGSTON, N.J., Oct.
COLUMBUS, Ohio, Oct.
In its thirty-six year history, the American Parkinson Disease Association Cozias Fellowship has been awarded to only twenty-eight scientific investigators New
Sales of a Novel Antipsychotic and an Improved Rescue Therapy Will Contribute Approximately $1 Billion to the PD Market in 2023, According to Findings from Decision Resources Group BURLINGTON,
- To give a box on the ear to.
More Images (1 images) »